Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.930
+0.410 (9.07%)
At close: Feb 6, 2026, 4:00 PM EST
4.720
-0.210 (-4.26%)
After-hours: Feb 6, 2026, 7:51 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $318.33 million as of February 6, 2026. Its market cap has increased by 376.84% in one year.
Market Cap
318.33M
Enterprise Value
94.68M
1-Year Change
376.84%
Ranking
Category
Stock Price
$4.93
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $318.33M, a decrease of -12.99%. That is a compound annual growth rate of -3.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 318.33M | -25.08% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 341.98M |
| Foghorn Therapeutics | 332.74M |
| Aldeyra Therapeutics | 332.70M |
| Atea Pharmaceuticals | 324.23M |
| Candel Therapeutics | 320.06M |
| X4 Pharmaceuticals | 311.27M |
| AC Immune | 310.68M |
| PepGen | 307.99M |